Blog category: News

Robotic knee surgery shown to be a pointless marketing sham!

“Does Robotic-assisted TKA Result in Better Outcome Scores or Long-Term Survivorship Than Conventional TKA? A Randomized, Controlled Trial.”
Young-Hoo et al.
Clinical Orthopaedics and Related Research Feb 2020; 478(2): 266-275

Researchers from South Korea have published a Level 1 (the highest possible quality) study with long-term (10-year!) outcomes investigating the use of robotics for knee replacement surgery. In this study about 700 knee replacement procedures performed robotically were compared to about 700 ‘routine’ knee replacements, with patients being followed up prospectively and with clinical and radiological outcomes being evaluated.

The authors found no differences between robotic-assisted knee replacement and conventional knee replacement surgery in terms of functional outcome scores, aseptic loosening, overall survivorship and complications. The authors conclude that “Considering the additional time and expense associated with robotic-assisted TKA, we cannot recommend its widespread use.”

CLICK HERE to read more

Conformis iTotal-CR Knee Replacement Awarded “5A” Rating from ODEP

ODEP is an independent panel of leading orthopedic surgeons and experts in the UK that evaluates data related to use of hip and knee implant technologies and provides a rating to indicate performance in key areas including survivorship. ODEP provides the National Health Service (NHS) with an approved list of products that meet the revision rate standard set by the National Institute for Health and Care Excellence (NICE) in the UK.

“We are pleased to have received the ODEP 5A rating,” said Mark Augusti, Chief Executive Officer and President of Conformis. “This rating provides another independent verification that our design philosophy, predicated on patient-conforming implants, results in performance where it counts the most—in patients. We hope that this 5A rating will provide more confidence to physicians that are considering offering our unique technology to their patients. In addition, we believe our results should provide an opportunity for Conformis to expand availability of our product at NHS facilities in the United Kingdom.”

CLICK HERE for the full story